US HB7646 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 3 2022 - 25% progression, died in committee
Action: 2022-05-03 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 3 2022 - 25% progression, died in committee
Action: 2022-05-03 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to notify the public about an emerging signal concerning a medical device in order to reduce or limit the number of patients exposed to a potential risk identified based on such emerging signal, and for other purposes.
Title
Emerging Signals Modernization Act of 2022
Sponsors
| Rep. Brett Guthrie [R-KY] | Rep. Seth Moulton [D-MA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-05-03 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-05-03 | House | Introduced in House |
Same As/Similar To
SB4349 (Related) 2022-06-06 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7646/all-info |
| Text | https://www.congress.gov/117/bills/hr7646/BILLS-117hr7646ih.pdf |
